CA1328877C - Agents antihypercholesterolemiants - Google Patents

Agents antihypercholesterolemiants

Info

Publication number
CA1328877C
CA1328877C CA000604835A CA604835A CA1328877C CA 1328877 C CA1328877 C CA 1328877C CA 000604835 A CA000604835 A CA 000604835A CA 604835 A CA604835 A CA 604835A CA 1328877 C CA1328877 C CA 1328877C
Authority
CA
Canada
Prior art keywords
hydroxy
oxo
ethyl
pyran
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000604835A
Other languages
English (en)
Inventor
Kenneth E. Wilson
Gerald E. Stokker
Ta Jyh Lee
Michael S. Schwartz
Henry Joshua
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/363,792 external-priority patent/US4968693A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA1328877C publication Critical patent/CA1328877C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
CA000604835A 1989-06-09 1989-07-05 Agents antihypercholesterolemiants Expired - Fee Related CA1328877C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/363,792 US4968693A (en) 1988-03-02 1989-06-09 3-keto HMG-COA reductase inhibitors
US363,792 1989-06-09

Publications (1)

Publication Number Publication Date
CA1328877C true CA1328877C (fr) 1994-04-26

Family

ID=23431752

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000604835A Expired - Fee Related CA1328877C (fr) 1989-06-09 1989-07-05 Agents antihypercholesterolemiants

Country Status (14)

Country Link
JP (1) JPH0324033A (fr)
CN (1) CN1047863A (fr)
AU (1) AU618106B2 (fr)
CA (1) CA1328877C (fr)
DK (1) DK330389A (fr)
FI (1) FI893272A (fr)
HU (1) HUT54133A (fr)
IE (1) IE892191L (fr)
IL (1) IL90847A0 (fr)
NO (1) NO892761L (fr)
NZ (1) NZ229806A (fr)
PT (1) PT91204B (fr)
YU (1) YU144589A (fr)
ZA (1) ZA895140B (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents

Also Published As

Publication number Publication date
DK330389A (da) 1990-12-10
DK330389D0 (da) 1989-07-04
NZ229806A (en) 1991-12-23
AU3783889A (en) 1990-12-13
YU144589A (en) 1990-12-31
NO892761D0 (no) 1989-07-04
JPH0324033A (ja) 1991-02-01
NO892761L (no) 1990-12-10
PT91204A (pt) 1991-02-08
PT91204B (pt) 1995-03-31
AU618106B2 (en) 1991-12-12
FI893272A (fi) 1990-12-10
IL90847A0 (en) 1990-02-09
IE892191L (en) 1990-12-09
CN1047863A (zh) 1990-12-19
ZA895140B (en) 1990-03-28
FI893272A0 (fi) 1989-07-05
HUT54133A (en) 1991-01-28

Similar Documents

Publication Publication Date Title
US5021453A (en) 3-keto HMG-CoA reductase inhibitors
US4940727A (en) Novel HMG-CoA reductase inhibitors
US4968693A (en) 3-keto HMG-COA reductase inhibitors
US5116870A (en) HMG-CoA reductase inhibitors
US5102911A (en) 4-Substituted HMG-CoA reductase inhibitors
CA1340331C (fr) Inhibiteurs de la reductase hmg-coa
US4319039A (en) Preparation of ammonium salt of hypocholesteremic fermentation product
US4342767A (en) Hypocholesteremic fermentation products
US4294846A (en) Hypocholesteremic fermentation products and products of preparation
EP0022478B1 (fr) Polyhydro-3,7-diméthyl-8-(2-(tétrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-éthyl)-1-naphtylényl-2-méthylbutanoates, les hydroxy-acides correspondants, procédé de préparation et compositions pharmaceutiques les contenant
US4963538A (en) 5-oxygenated HMG-CoA reductase inhibitors
US4970231A (en) 4-substituted HMG-CoA reductase inhibitors
US5098931A (en) 7-substituted HMG-CoA reductase inhibitors
EP0323867B1 (fr) Inhibiteurs de la HMG-COA réductase
US4420491A (en) Hypocholesteremic fermentation products and process of preparation
US5010105A (en) Antihypercholesterolemic compounds
USRE36481E (en) HMG-CoA reductase inhibitors
US4997849A (en) Microbial transformation of simvastatin
EP0415488B1 (fr) Inhibiteurs d'HMG-COA réductase substitués en 7
CA1328877C (fr) Agents antihypercholesterolemiants
US5041562A (en) 3-keto HMG-CoA reductase inhibitors
EP0409399B1 (fr) Inhibiteurs de 3-céto HMG-CoA réductase
US5001241A (en) 3-KETO HMG-CoA reductase inhibitors
US4937259A (en) Antihypercholesterolemic compounds
JP2582785B2 (ja) 新規ＨＭＧ−ＣｏＡレダクタ−ゼ阻害剤

Legal Events

Date Code Title Description
MKLA Lapsed